Gene

Search results

No.	KEGG PATHWAY	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	AGE-RAGE signaling pathway in diabetic complications 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
2	AGE-RAGE signaling pathway in diabetic complications 💬	[2] VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
3	Bladder cancer 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
4	Bladder cancer 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
5	Calcium signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
6	Calcium signaling pathway 💬	[2] VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
7	Chemical carcinogenesis - reactive oxygen species 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
8	Chemical carcinogenesis - reactive oxygen species 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
9	Chemical carcinogenesis - receptor activation 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
10	Chemical carcinogenesis - receptor activation 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
11	Collecting duct acid secretion 💬	[2] ATP4A, ATP4B 💬	Lansoprazole 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬 💬
12	EGFR tyrosine kinase inhibitor resistance 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
13	EGFR tyrosine kinase inhibitor resistance 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
14	Fluid shear stress and atherosclerosis 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
15	Fluid shear stress and atherosclerosis 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
16	Focal adhesion 💬	[3] PGF, VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
17	Focal adhesion 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
18	Gastric acid secretion 💬	[2] ATP4A, ATP4B 💬	Lansoprazole 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬 💬
19	HIF-1 signaling pathway 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
20	HIF-1 signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
21	Human cytomegalovirus infection 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
22	Human cytomegalovirus infection 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
23	Human papillomavirus infection 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
24	Human papillomavirus infection 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
25	Kaposi sarcoma-associated herpesvirus infection 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
26	Kaposi sarcoma-associated herpesvirus infection 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
27	MAPK signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
28	MAPK signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
29	Metabolic pathways 💬	[2] ATP4A, ATP4B 💬	Lansoprazole 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬 💬
30	MicroRNAs in cancer 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
31	MicroRNAs in cancer 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
32	Oxidative phosphorylation 💬	[2] ATP4A, ATP4B 💬	Lansoprazole 💬	Lansoprazole	[7] 63, 71, 85, 98, 166, 222, 299 💬 💬
33	Pancreatic cancer 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
34	Pancreatic cancer 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
35	Pathways in cancer 💬	[3] PGF, VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
36	Pathways in cancer 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
37	PI3K-Akt signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
38	PI3K-Akt signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
39	Proteoglycans in cancer 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
40	Proteoglycans in cancer 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
41	Rap1 signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
42	Rap1 signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
43	Ras signaling pathway 💬	[3] PGF, VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
44	Ras signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
45	Relaxin signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
46	Relaxin signaling pathway 💬	[2] VEGFA, VEGFB 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
47	Renal cell carcinoma 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
48	Renal cell carcinoma 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
49	Rheumatoid arthritis 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
50	Rheumatoid arthritis 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬
51	VEGF signaling pathway 💬	[1] VEGFA 💬	Aflibercept 💬	Aflibercept	[2] 90, 166 💬 💬
52	VEGF signaling pathway 💬	[1] VEGFA 💬	Ranibizumab 💬	Ranibizumab	[4] 34, 166, 227, 301 💬 💬